Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02252146 |
Title | Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88L265P Mutation |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Idera Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UCLA Medical Center | Los Angeles | California | 90095 | United States | Details | |
Emory University | Atlanta | Georgia | 30306 | United States | Details | |
Cancer Care Specialists of Illinois | Decatur | Illinois | 62526 | United States | Details | |
Horizon Bio Advance | Lafayette | Indiana | 47905 | United States | Details | |
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
Washington University | Saint Louis | Missouri | 63110 | United States | Details | |
Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
Columbia University Medical Center | New York | New York | 10019 | United States | Details | |
Cleveland Clinic | Cleveland | Ohio | 44109 | United States | Details | |
Vanderbilt Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |